![Dov V. Shimon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dov V. Shimon
Director Ejecutivo en Sagax Medical Technologies, Inc. .
Cargos activos de Dov V. Shimon
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Sagax Medical Technologies, Inc.
![]() Sagax Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Part of Shimoco LLC, Sagax Medical Technologies, Inc. develops proprietary solutions to reduce the risk of strokes and other serious complications resulting from cardiac procedures, as well as naturally occurring Cardioembolic Strokes. The company is based in Herzliya, Israel. The Israeli company was founded by Dov V. Shimon, who has been the CEO since incorporation. Sagax Medical Technologies was acquired by Shimoco LLC from MIV Therapeutics, Inc. on December 28, 2007. | Director Ejecutivo | 01/01/2002 | - |
Fundador | 20/05/2011 | - | |
Presidente | 01/01/2002 | - |
Historial de carrera de Dov V. Shimon
Antiguos cargos conocidos de Dov V. Shimon.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Keystone Heart Ltd.
![]() Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Director Técnico/Científico/I+D | 20/05/2011 | 25/04/2012 |
Fundador | 20/05/2011 | 25/04/2012 | |
Presidente | 20/05/2011 | 25/04/2012 | |
MIV Therapeutics, Inc.
![]() MIV Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services MIV Therapeutics, Inc. is an advanced stage, research and development company. It is engaged in developing a next-generation line of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents and for a broad range of other implantable medical devices. The company was founded by Alan P. Lindsay on January 20, 1999 and is headquartered in Vancouver, Canada. | Director Técnico/Científico/I+D | - | 13/11/2007 |
Utah Artificial Heart Institute | Director/Miembro de la Junta | - | - |
Formación de Dov V. Shimon.
The Hebrew University of Jerusalem | Undergraduate Degree |
Estadísticas
Internacional
Israel | 4 |
Canadá | 2 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
President | 2 |
Sectorial
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
MIV Therapeutics, Inc.
![]() MIV Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services MIV Therapeutics, Inc. is an advanced stage, research and development company. It is engaged in developing a next-generation line of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents and for a broad range of other implantable medical devices. The company was founded by Alan P. Lindsay on January 20, 1999 and is headquartered in Vancouver, Canada. | Commercial Services |
Sagax Medical Technologies, Inc.
![]() Sagax Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Part of Shimoco LLC, Sagax Medical Technologies, Inc. develops proprietary solutions to reduce the risk of strokes and other serious complications resulting from cardiac procedures, as well as naturally occurring Cardioembolic Strokes. The company is based in Herzliya, Israel. The Israeli company was founded by Dov V. Shimon, who has been the CEO since incorporation. Sagax Medical Technologies was acquired by Shimoco LLC from MIV Therapeutics, Inc. on December 28, 2007. | Health Technology |
Utah Artificial Heart Institute | |
Keystone Heart Ltd.
![]() Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Dov V. Shimon
- Experiencia